Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Descamps

Showing results (1-10 of 336) with videos related to

Pageof 34
Sort By:
Viruses|January 19, 2018
Resistance to HIV Integrase Inhibitors: About R263K and E157Q MutationsCharlotte Charpentier, Diane Descamps
AIDS Reviews|November 6, 2002
NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimensVéronique Joly, Diane Descamps, Patrick Yeni
Scandinavian Journal of Infectious Diseases|December 13, 2002
Transfusion-related infectious mononucleosisPierre Tattevin, Anne-Claude Crémieux, Diane Descamps, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biasesPhilippe Flandre, Christine Durier, Diane Descamps, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 18, 2016
Hiv-2 molecular epidemiologyBenoit Visseaux, Florence Damond, Sophie Matheron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2021
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2Noémie Zucman, Fabrice Uhel, Diane Descamps, et al.
Virologie (Montrouge, France)|December 13, 2019
[Physiopathology of HIV-2 infection]Benoît Visseaux, Quentin Le Hingrat, Florence Damond, et al.
Journal of the International AIDS Society|November 15, 2014
Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatmentAnne-Genevieve Marcelin, Charlotte Charpentier, Marc Wirden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Estimating and comparing reduction in HIV-1 RNA in clinical trials using methods for interval censored dataPhilippe Flandre, Alexandre Alcais, Diane Descamps, et al.
Viruses|February 28, 2023
Future of Antiretroviral Drugs and Evolution of HIV-1 Drug ResistanceCharlotte Charpentier, Quentin Le Hingrat, Valentine Marie Ferré, et al.
Pageof 34

Showing results (1-10 of 336) with videos related to

Sort By:
Pageof 34
Viruses|January 19, 2018
Resistance to HIV Integrase Inhibitors: About R263K and E157Q MutationsCharlotte Charpentier, Diane Descamps
AIDS Reviews|November 6, 2002
NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimensVéronique Joly, Diane Descamps, Patrick Yeni
Scandinavian Journal of Infectious Diseases|December 13, 2002
Transfusion-related infectious mononucleosisPierre Tattevin, Anne-Claude Crémieux, Diane Descamps, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biasesPhilippe Flandre, Christine Durier, Diane Descamps, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 18, 2016
Hiv-2 molecular epidemiologyBenoit Visseaux, Florence Damond, Sophie Matheron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 2021
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2Noémie Zucman, Fabrice Uhel, Diane Descamps, et al.
Virologie (Montrouge, France)|December 13, 2019
[Physiopathology of HIV-2 infection]Benoît Visseaux, Quentin Le Hingrat, Florence Damond, et al.
Journal of the International AIDS Society|November 15, 2014
Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatmentAnne-Genevieve Marcelin, Charlotte Charpentier, Marc Wirden, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Estimating and comparing reduction in HIV-1 RNA in clinical trials using methods for interval censored dataPhilippe Flandre, Alexandre Alcais, Diane Descamps, et al.
Viruses|February 28, 2023
Future of Antiretroviral Drugs and Evolution of HIV-1 Drug ResistanceCharlotte Charpentier, Quentin Le Hingrat, Valentine Marie Ferré, et al.
Pageof 34